BATTLE researchers identify new biomarkers for EGFR inhibition

Scientists are continuing their work on the Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination trial — known more commonly as the BATTLE trial — and presented updated results at the AACR 102nd Annual Meeting 2011, held here April 2-6.

Read the whole article on Physorg

More from Physorg